Search results
Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational...
Newswise· 6 days agoNew York, NY [April 29, 2024]—Miriam Merad, MD, PhD, a world-renowned immunologist, has been...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 2 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
QT-Prolonging Meds Commonly Doled Out to Dialysis Patients
MedPage Today· 5 days agoMost scripts originated from clinicians other than nephrologists
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days ago- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies - SITC 2023 Presentation of the Phase 1 Topline Clinical and Mechanism Data of BeyondSpring’s Lead Asset Plinabulin
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoG1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement ...